← Evidence map

ArticleClinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico2017

M30/M65 ratio predicts the outcome of paclitaxel chemotherapy for NSCLC.

T Chu et al.PubMed ↗Publisher ↗

No numbers read from the abstract.

2 papers cite it

2017
2018
2019
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 27468866